PALLAS trial: Adjuvant palbociclib in HR+/HER2- early breast cancer - report from SABCS2021

from Medical Digest & Congress Report · host Medical Congress News

Professor Michael Gnant speaks about the final results from 5,760 patients in the randomized phase III PALLAS trial. Video: https://congressreport.eu/scientific-contents/interview:pallas-trial-adjuvant-palbociclib-hrher2-early-breast-cancer

Episode metadata supplied by the publisher feed · Published Dec 15, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

PALLAS trial: Adjuvant palbociclib in HR+/HER2- early breast cancer - report from SABCS2021

0:00 8:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 8 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 15, 2021.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!